Late Sequelae in Oncology
Increasing survival figures and the use of more intense combined treatment regimens in modern oncology have raised the problem of late therapeutic sequelae in long-term survivors after cancer. Recent scientific approaches to late sequelae concentrate on the evaluation of subclinical changes with sop...
Other Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1995, 1995
|
Edition: | 1st ed. 1995 |
Series: | Radiation Oncology
|
Subjects: | |
Online Access: | |
Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- 1 Individual Variation of Radio- and Chemosensitivity
- 1.1 Impact of Endogenous and Exogenous Factors on Radiation Sequelae
- 1.2 Endogenous and Exogenous Factors Modifying Chemosensitivity to Cytostatic Drugs
- 2 Neurotoxicity
- 2.1 Radiation-Induced Injury of the Central Nervous System
- 2.2 Cytostatic-Induced Central Nervous System Abnormalities
- 2.3 Radiation Myelopathy
- 2.4 Acute and Late Toxicity on Peripheral Nerves After Radiotherapy
- 2.5 Acute and Late Toxicity on Peripheral Nerves After Chemotherapy — A Review
- 2.6 Endocrine Dysfunction After Brain Tumor Therapy in Children
- 2.7 Endocrine Dysfunction in Adults After Radiotherapy for Pituitary Adenomas and Suprasellar Tumors
- 2.8 Late Sequelae Affecting the Ear
- 2.9 Ototoxicity in Pediatric Oncology
- 3 Skin and Mucosal Toxicity
- 3.1 Biological Basis for Skin and Mucosal Toxicity
- 3.2 Radiation-Induced Fibrosis: Experimental Studies
- 3.3 Lymphedema of the Arm After Treatment of Breast Cancer
- 6.1 Nephrotoxicity of Ifosfamide in Children
- 6.2 Radiation Nephritis
- 7 Gonadal Toxicity
- 7.1 Long-Term Gonadal Dysfunction and Its Impact on Bone Mineralization in Patients Following COPP/ABVD Chemotherapy for Hodgkin’s Disease
- 7.2 Gonadal Dysfunction After Radiotherapy
- 8 Disturbances of Sceletal Growth
- 8.1 Dose-Time Considerations for Skeletal Growth Disturbances After Radiotherapy
- 8.2 Disturbances in Growth of Bone, Muscle, and Fat Tissue Following Irradiation in Childhood
- 8.3 Growth Failure Secondary to Radiotherapy of Brain Tumors in Childhood
- 9 Cancerogenesis
- 9.1 Experiments on the Carcinogenic Potential of Antineoplastic Agents
- 9.2 Secondary Malignancies Following Cytotoxic Chemotherapy
- 9.3 Secondary Malignancies After Radiotherapy
- List of Contributors
- 3.4 Skin and Mucosal Damage After Radiotherapy for Head and Neck Tumors
- 3.5 Mucosal Toxicity After Radiochemotherapy
- 3.6 Complications of the Small Intestine and the Pancreas After Intraoperative Radiotherapy
- 3.7 Skin Toxicity
- 4 Lung Toxicity
- 4.1 Radiation Pneumopathy — Experimental and Clinical Data
- 4.2 Lung Toxicity of Chemotherapeutic Agents
- 4.3 Differential Diagnosis of Treatment Sequelae in the Lung
- 5 Cardiotoxicity
- 5.1 Evaluation of Late Cardiotoxicity by Pulsed Doppler Echocardiography in Patients Treated for Hodgkin’s Disease
- 5.2 Anthracycline-Induced Cardiotoxicity in Children: Pathophysiology and Prevention
- 5.3 Radiation-Induced Cardiotoxicity: Experimental Data
- 5.4 Cardiotoxicity After Megavoltage Irradiation and Chemotherapy for Hodgkin’s Disease with Special Emphasis on Coronary Heart Disease Mortality — The Freiburg Experience 1940-1992
- 5.5 Cardiac Morbidity and Mortality Followig Radiotherapy
- 6 Nephrotoxicity